ASTS vs REGN
Ast Spacemobile Inc (ASTS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Ast Spacemobile Inc (ASTS) is a communication equipment company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ASTS revenue for 2024-12-31 was $4.4M. Net income was -$526.3M. ASTS currently screens at market cap $33.16B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ASTS currently screens at market cap $33.16B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ASTS and REGN stock pages for the full models.
Not investment advice.